Inaugural PEDS GI Connect Conference - Newsletter

Thursday, May 1, 2025, 8:00 AM - Thursday, April 30, 2026, 11:59 PM

AMA PRA Category 1 Credits™ (1.00 hours), AMA PRA Category 1 Credits™ Designated (1.00 hours)


The Inaugural PEDS GI Connect Conference is a two-day event focused on promoting the collaboration and exchange of knowledge among pediatric gastrointestinal healthcare professionals. Attendees will have the opportunity to participate in interactive sessions covering a wide range of topics within the field of pediatric gastroenterology.

There is no fee for this educational activity. To view this activity, register on the GI Health Foundation website.

1. Describe evolving patient management and treatment strategies for GI disorders.
2. Integrate significant advances in therapeutic and diagnostic modalities into clinical practice.
3. Apply the latest clinical research, including future therapies and their role in the context of the current clinical paradigm.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and the Gi Health Foundation (GiHF). The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Declaration
According to the disclosure policy of the University of Cincinnati, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies within the last 24-months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence.

Disclaimer Statement
The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees professional development.

Off-Label Disclosure Statement
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

COI / Disclosure of Relationships with Ineligible Entities

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24 months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify from involvement in the planning and implementation of accredited continuing education any individuals (1) who refuse to provide this information or (2) whose conflicts of interests cannot be mitigated.

*Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant relationships have been mitigated. The following disclosures were made:

Planners/Course Directors/Speaker

Valeria Cohran, MD
Speaker: Alcresta Therapeutics, Abbott Nutrition, Takeda Pharmaceuticals, Nutrica
Advisor: Alcresta Therapeutics

Carlo Di Lorenzo, MD
Consultant: AbbVie, Bayer, Ironwood, Takeda

Amanda Muir, MD
Medical Advisor Board: Bristol Myers Squibb, Regeneron/Sanofi, Takeda, Uniquity

Joel Rosh, MD
Consultant: AbbVie, Janssen
DSMB Member: Janssen

The University of Cincinnati staff and the GI Health Foundation writers and staff have no relationships to disclose.

Speakers

Tanaz Danialifar, MD
Consultant: QOL Medical

Julie Khlevner, MD
Consultant: AbbVie, Ironwood
Speaker: Abbott Pediatric Nutrition, QOL Medical

Julie Messick
No financial relationships to disclose

Ashish Patel, MD
Consulting: AbbVie, Takeda
Speaker Bureau: Abbott Nutrition

Josh Wechsler, MD
Advisor: Bristol Myers Squibb
IDMC: AstraZeneca
Speaker/Consultant/Advisory: Regeneron/Sanofi

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant relationships have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.

Supported by an educational grant from Janssen Biotech Inc., administered by Janssen Scientific Affairs, LLC and MeadJohnson.